ferric ferrocyanide has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, X; Hong, H; Liu, Q; Liu, Y; Liu, Z; Luo, J; Pan, Y; Xue, J; Zhou, J | 1 |
| Hironishi, M; Senba, E; Ueyama, E | 1 |
2 other study(ies) available for ferric ferrocyanide and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood-Brain Barrier Crossing and Protection for Parkinsonian Therapy.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Cell Line, Tumor; Drug Liberation; Ferrocyanides; Humans; Imidazoles; Infrared Rays; Male; Mice, Inbred C57BL; Mitochondria; Nanocomposites; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Quercetin; Rats, Sprague-Dawley; Zeolites | 2021 |
Systematic expression of immediate early genes and intensive astrocyte activation induced by intrastriatal ferrous iron injection.
Topics: Animals; Astrocytes; Behavior, Animal; Coloring Agents; Corpus Striatum; Dopamine; Ferrocyanides; Ferrous Compounds; Genes, Immediate-Early; Geniculate Bodies; Hydroxyl Radical; Male; Microinjections; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics | 1999 |